BAYER Said to Offer Assets, Cash in Race for MERCK’s Unit

▲Cont'd on Bloomberg
Cont’d on Bloomberg

Bayer AG (BAYN) moved a step closer to winning Merck & Co. (MRK)’s consumer business after lead rival Reckitt Benckiser Group Plc (RB/) walked away from the deal because the asset became too expensive.

“We are a highly disciplined acquirer with strict return metrics, which we will not break,” Reckitt Benckiser Chief Executive Officer Rakesh Kapoor said in an e-mailed statement.

Bayer offered to pay cash and swap assets from animal-health, pharmaceuticals, and oncology businesses or create a joint-venture with Merck that includes these, two people familiar with the matter said, asking not to be identified discussing private information. A heated contest between the two bidders means Merck may fetch more than $14 billion in a sale of the the unit, well over early estimates of its value, the people said earlier today.

By Manuel Baigorri, David Welch and Naomi Kresge


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s